[EN] INHIBITORS OF CELLULAR METABOLIC PROCESSES<br/>[FR] INHIBITEURS DE PROCESSUS MÉTABOLIQUES CELLULAIRES
申请人:AGIOS PHARMACEUTICALS INC
公开号:WO2018045071A1
公开(公告)日:2018-03-08
The present disclosure provides MAT2A inhibitor compounds that are useful as therapeutic agents for treating malignancies, and wherein the compounds conform to general formula (IA), wherein RA, RB, RC, RD, and RE are defined herein.